Skip to main content
. Author manuscript; available in PMC: 2008 Mar 30.
Published in final edited form as: Neurosci Lett. 2007 Jan 14;415(3):264–268. doi: 10.1016/j.neulet.2007.01.028

Fig. 1.

Fig. 1

Bodyweight measurements and time recordings on the wire mesh ascending test monitor pre-symptomatic disease progression. Bodyweight measurements (a) and wire mesh ascending test time recordings (b). wt, wild-type littermates (n=6). ALS, transgenic ALS rats (n=10). Male:female ratio 1:1 in both groups. Black arrows represent the average age of symptomatic disease onset (167.6 days). Dot line depicts the first value in ALS rats that is significantly different from wild-type littermates. *p < 0.05. ** p < 0.01. ***p < 0.001.